Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled, Multicenter, Dose-range, Proof-of-concept, 24-week Treatment Study of IVA337 in Adult Subjects With Nonalcoholic Steatohepatitis (NASH)

NCT03008070 is registered in ClinicalTrials.gov with Inventiva Pharma as lead sponsor.

NCT NCT03008070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03008070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled, Multicenter, Dose-range, Proof-of-concept, 24-week Treatment Study of IVA337 in Adult Subjects With Nonalcoholic Steatohepatitis (NASH)
Lead sponsor
Inventiva Pharma
Phase
Phase 2
Overall status
Completed
Start date
February 7, 2017
Completion date
March 16, 2020
Enrollment
247 (actual)
Sites
85

Conditions

As the registry lists them; a condition with its own page is linked.

non-alcoholic steatohepatitis (nash)